Researchers from Boston's Cancer Institute and the University of California, Berkeley, have unveiled a groundbreaking fat-burning enzyme called PM20D1, detailed in the journal Cell. Produced by cells, it generates N-acylated amino acids that supercharge energy expenditure—burning calories even at rest. In tests, injecting these amino acids into obese mice on a high-fat diet led to significant fat loss after just eight days.
With U.S. obesity rates among the world's highest, this could transform public health efforts. New treatments harnessing these amino acids may soon target this epidemic.
In 2010, Michelle Obama launched the “Let’s Move” campaign to help obese children adopt healthier lifestyles. Confirming PM20D1's benefits for obesity, diabetes, and fatty liver will require further studies before human trials—but the potential is exciting.
